Line 171: |
Line 171: |
| | | | | |
| |- | | |- |
− | |Childhood myelodysplastic neoplasm with increased blasts||Disease||Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.|| || || || ||FQR|| || | + | |Childhood myelodysplastic neoplasm with increased blasts||Disease|| || || || || ||FQR|| || |
− | |
| + | |Refractory Cytopenia of Childhood |
− | |
| + | |Xiaoli Du, Ph.D; Teresa A. Smolarek, Ph.D, FACMG Division of Human Genetics, Cincinnati Children's Hospital Medical Center |
− | | | + | |Complete |
| | | | | |
| | | | | |
| |- | | |- |
− | |Chronic myelomonocytic leukaemia||Disease||Linsheng Zhang, MD, PhD|| || || || ||FQR|| || | + | |Chronic myelomonocytic leukaemia||Disease|| || || || || ||FQR|| || |
− | | | + | |Chronic Myelomonocytic Leukemia (CMML) |
− | | | + | |Linsheng Zhang, MD, PhD |
− | | | + | |Complete |
| | | | | |
| | | | | |
| |- | | |- |
− | |Myelodysplastic/myeloproliferative neoplasm with neutrophilia||Disease||Linsheng Zhang, MD, PhD|| || || || ||FQR|| || | + | |Myelodysplastic/myeloproliferative neoplasm with neutrophilia||Disease|| || || || || ||FQR|| || |
− | | | + | |Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative |
− | | | + | |Linsheng Zhang, MD, PhD |
− | | | + | |Complete |
| | | | | |
| | | | | |
| |- | | |- |
− | |Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis||Disease||Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine|| || || || ||FQR|| || | + | |Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis||Disease|| || || || || ||FQR|| || |
− | |
| + | |Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) |
− | |
| + | |Anamaria Munteanu, MD, Ph.D, Harbor-UCLA Medical Center, Fabiola Quintero-Rivera, University of California Irvine |
− | | | + | |Complete |
− | | | + | |Date page was created |
| | | | | |
| |- | | |- |